Searched for
MSD GLOBAL OPERATIONS
MSD inaugurates 2.5 lakh sq ft tech centre in HyderabadGlobal biopharmaceutical company MSD has opened a new technology centre in Hyderabad. This facility will enhance the company's digital, dat...- Aurobindo Pharma enters biologics contract manufacturing with Rs 1,200-crore Telangana facilityAurobindo Pharma has launched TheraNym, a major biologics manufacturing plant in Telangana. This facility will produce biologic medicines f...
- Organon appoints Vivek Soares as country lead for India, South AsiaUS-based healthcare firm Organon announced Vivek Soares as the new country lead for India and South Asia, bringing over 20 years of biophar...
- AI firm Mad Street Den raises $30 million in funding led by Avatar Growth CapitalEnterprise AI company Mad Street Den (MSD) has raised $30 million in its Series C funding round, led by Avatar Growth Capital. Existing inv...
- Specialty chemicals startup Covvalent raises $4.3 million in seed funding from Nexus VP, othersThe company said it plans to use the funds to strengthen its tech infrastructure and for recruitment across the international business deve...
- India, US to launch emerging defence capabilities dialogue soonThe Indian delegation for the inter-sessional meeting on Wednesday was led by Vani Rao, Additional Secretary (Americas) in the Ministry of ...
- MSD brings shingles vaccine to boost India offeringIn extreme cases, shingles can also result in pneumonia, hearing problems, blindness, encephalitis (brain inflammation) and death.
- MSD launches medical, healthcare website called 'Univadis'Univadis is an online resource for healthcare professionals launched in 40 countries, available in 17 languages, with 20 mn registered user...
- Cipla to market MSD's HIV drug 'raltegravir' in IndiaMSD in India Managing Director K G Ananthakrishnan said the partnership is aligned with the company's commitment towards patients in India.
- MSD India to invest $10 million to reduce maternal mortalityMSD for Mothers, drug firm would partner three non-governmental organisations across three states in India- Rajasthan, Jharkhand and Uttar ...
- Hilleman Laboratories loses key executivesSome of the top executives, including the founding CEO, have moved on from Delhi-based vaccine research firm Hilleman Laboratories.
- Merck scouts for marketing, licensing pacts with Indian cosMerck & Co, is looking at in-licensing and co-marketing arrangements with Indian pharma cos as it wants to realise its ambitions to become ...
- Relocation triggers exits at Merck armAround 50 executives quit MSD, the Indian arm of Merck & Co, in the past few months — most opted out due to the company’s decision to reloc...
- 'We will continue to sell our patented drugs with India-specific pricing'KG Ananthakrishnan, MD, MSD India spoke on future strategy and shared his views on Indian govt's proposals on contentious issues such as co...
- Merck plans to shift India head office to MumbaiUS-based drugmaker Merck plans to relocate headquarter of its India office to Mumbai, making it the third major pharma company to shift key...
- Merck buys Schering-Plough in $41.1b cash-&-stock dealUS-based Merck & Co is acquiring Schering-Plough for $41.1 billion in a cash-and-stock deal, to create a $47 billion drug major.
- Merck buys Schering-Plough for $41 bn to access new drugsUS-based Merck & Co on Monday said it is acquiring Schering Plough for $41.1 bn in a cash-and-stock deal to create a $42-bn drug major.
- Merck subsidiary plans to launch patented drugsMerck Sharp & Dohme (MSD) Pharmaceuticals is betting big on India, an emerging market for its patented and first research-based vaccines an...
- MSD Pharma launches JANUVIA for diabetic careDrug firm MSD Pharmaceuticals today launched its patent medicine under the brand name 'JANUVIA' in diabetic care segment and aims to tap fo...
- US-based Merck to double workforce by year-endUS-based $25-billion Merck also plans to launch drugs targeted to Indian patients and introduce a competitive pricing pattern.
Load More
